Picture of Gujarat Themis Biosyn logo

GUJTHEM Gujarat Themis Biosyn Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual cashflow statement for Gujarat Themis Biosyn, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line409590775793655
Depreciation
Non-Cash Items-19.7-20.7-50.1-36-5.05
Other Non-Cash Items
Changes in Working Capital-301-189-355-156203
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities105403395642910
Capital Expenditures-30.6-139-237-746-1,162
Purchase of Fixed Assets
Other Investing Cash Flow Items8.06-15932.919443.3
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-22.5-298-204-552-1,118
Financing Cash Flow Items-4.5-2.05-1.11-0.894-4.28
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-51.6-140-133-85.9260
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash31.1-35.157.94.1452.2